SSG
CDMO

Summit Securities Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Summit Securities Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-29
Closed – – 604
2013
Q3 		$0 Buy
+29
New +$288 ﹤0.01% 568

Other funds holding CDMO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Summit Securities Group's CDMO Position: Q4 2013 in Review

Summit Securities Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2013, closing a stake of 29 shares.

Summit Securities Group first reported a position in CDMO in Q3 2013 and held it in 1 quarter. The position peaked at $0 in Q3 2013. 70 funds tracked by Wall St. Rank hold CDMO as of Q4 2013.

  • Summit Securities Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Summit Securities Group sold 29 Avid Bioservices, Inc. Common Stock shares in Q4 2013.
  • Summit Securities Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Summit Securities Group's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q3 2013.
  • 70 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2013.

Based on Summit Securities Group's 13F filing for Q4 2013, filed 13 Feb 2014.